Boehringer launches at long-end of Schuldschein mart

Boehringer Ingelheim, the German pharmaceutical group, has decided to tap the long end of the Schuldschein market by launching a 10 year deal. The note is understood to be the first of that tenor in 2009 and is clear sign of the market’s recovery, according to bankers.

  • 11 Jun 2009

Boehringer, which is unrated but considered to be a double-A credit, launched its Eu300m five, seven and ten year facility towards the end of last week. Respective guidance on the tranches is 190bp-215bp, 235bp-260bp and 280bp-310bp.

The deal is being led by Helaba, HSBC and LBBW.

Bankers in Germany said ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access: subs@globalcapital.com

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.

GlobalCapital European securitization league table

Rank Lead Manager/Arranger Total Volume $m No. of Deals Share % by Volume
1 BNP Paribas 14,443 29 18.07
2 Bank of America Merrill Lynch (BAML) 8,264 27 10.34
3 Lloyds Bank 7,329 24 9.17
4 Citi 6,748 19 8.44
5 JP Morgan 5,220 8 6.53

Bookrunners of Global Structured Finance

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 Citi 117,261.12 337 11.10%
2 Bank of America Merrill Lynch 94,723.52 272 8.97%
3 JPMorgan 92,612.23 269 8.77%
4 Wells Fargo Securities 82,597.19 239 7.82%
5 Credit Suisse 69,442.99 183 6.57%